LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Total Debt History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Debt | ₹1.07 Cr | ₹2.00 Cr | ₹2.04 Cr | ₹0.52 Cr | ₹5.07 Cr |
What is the latest Total Debt ratio of LINCOLN PHARMACEUTICALS ?
Year | Total Debt |
---|---|
Mar2024 | ₹1.07 Cr |
Mar2023 | ₹2.00 Cr |
Mar2022 | ₹2.04 Cr |
Mar2021 | ₹0.52 Cr |
Mar2020 | ₹5.07 Cr |
How is Total Debt of LINCOLN PHARMACEUTICALS Trending?
Years | Total Debt | % Change | |
---|---|---|---|
Mar2024 | ₹1.07 Cr | -46.57 | |
Mar2023 | ₹2.00 Cr | -2.30 | |
Mar2022 | ₹2.04 Cr | 293.08 | |
Mar2021 | ₹0.52 Cr | -89.75 | |
Mar2020 | ₹5.07 Cr | - |
Compare Total Debt of peers of LINCOLN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LINCOLN PHARMACEUTICALS | ₹1,320.3 Cr | -3.4% | -14.8% | 33.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹453,486.0 Cr | -0.6% | 1.3% | 65.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,321.0 Cr | -1.1% | 11.4% | 64% | Stock Analytics | |
CIPLA | ₹125,852.0 Cr | -2.3% | -6.8% | 33.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,799.0 Cr | 1.5% | 1% | 22.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹102,726.0 Cr | -4.2% | -8.1% | 72.3% | Stock Analytics |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LINCOLN PHARMACEUTICALS | -3.4% |
-14.8% |
33.3% |
SENSEX | -0.7% |
-2.4% |
22% |
You may also like the below Video Courses